Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alembic Animal Health appears to refer to the animal health division of Alembic Pharmaceuticals, an active, publicly traded Indian pharmaceutical company, rather than to a separately incorporated company. The division markets veterinary products for livestock, poultry, and companion animals, with a portfolio anchored in hematinics, antibiotics, and other branded animal-health products. Public company materials describe strong commercial traction in India and highlight major brands including Sharkoferrol, Moxel, Xceft, and Mceft. Alembic has also expanded the division through partnerships such as its strategic commercial agreement with Amlan International to introduce poultry health feed-additive solutions in India. Because the requested name does not appear to map to a standalone legal entity, the information below is best understood as referring to Alembic Pharmaceuticals' animal health business unit.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alembic Animal Health.